StockNews.com started coverage on shares of NeuroMetrix (NASDAQ:NURO – Free Report) in a research note issued to investors on Friday morning. The firm issued a sell rating on the medical device company’s stock. NeuroMetrix Price Performance Shares of NASDAQ NURO opened at $4.70 on Friday. NeuroMetrix has a 1 year low of $2.70 and a […]